ENABLEX PACKAGE INSERT PDF

ENABLEX PACKAGE INSERT PDF

Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Enablex (darifenacin). mg and 15 mg darifenacin (as darifenacin hydrobromide). Muscarinic M3 This leaflet is part III of a three-part Product. Monograph. Enablex (darifenacin) is used to treat symptoms of overactive bladder. Includes Enablex side effects, interactions and indications. See also: Drug Interactions ( in more detail).

Author: Vomi Gardalkree
Country: Germany
Language: English (Spanish)
Genre: Literature
Published (Last): 3 July 2005
Pages: 236
PDF File Size: 6.21 Mb
ePub File Size: 17.82 Mb
ISBN: 587-9-66898-664-8
Downloads: 86677
Price: Free* [*Free Regsitration Required]
Uploader: Kazrataur

Other causes of frequent urination heart failure or renal disease should be assessed before treatment with Emselex.

Emselex 7.5mg prolonged release tablets

Concomitant treatment with potent CYP2D6 inhibitors results in an increase in exposure e. The use of agents such as physostigmine can assist in reversing such symptoms. Date of revision of the text. Take Enablex exactly as prescribed by your doctor. Drugs and Supplements Darifenacin Oral Route.

The steady-state volume of distribution V ss is estimated to be litres. Advertising and sponsorship policy Advertising and sponsorship opportunities.

Darifenacin (Oral Route) Side Effects – Mayo Clinic

FDA alerts for all medications. However, protein binding of darifenacin was affected by moderate hepatic impairment. Therapeutic drug monitoring for digoxin should be performed when initiating and ending darifenacin treatment as well as changing the darifenacin dose. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy, not alert, or not able to see well.

  INTRADA ET RIGAUDON HENRY PURCELL PDF

Studies in animals have shown toxicity to parturition for details, see section 5. Respiratory, thoracic and mediastinal disorders. Cystometric studies performed with darifenacin in patients with involuntary bladder pacjage showed increased bladder capacity, increased volume threshold for packqge contractions and diminished frequency of unstable detrusor contractions. No dose adjustment is required in patients with impaired renal function.

To email a medicine you must sign up and log in. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. Method of administration Emselex is for oral use. As with other antimuscarinic agents, Emselex packave produce effects such as dizziness, blurred vision, insomnia and somnolence.

Hepatic impairment No dose adjustment is required in patients with mild hepatic impairment Child Pugh A. Emselex is contraindicated in patients with: Drug Interactions in more detail. The dose of this medicine will be different for different patients.

Date of first authorisation: Be sure to ask your doctor about anything you do not understand. The presence of other medical problems may affect the use of this medicine. Emselex is not recommended during pregnancy.

  AKTA KWSP TERKINI PDF

If you notice any other effects, check with your healthcare professional. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Polyethylene glycol Hypromellose Titanium dioxide Isnert Talc.

A decision whether to avoid breast-feeding or to abstain from Emselex therapy during lactation should be based on a benefit and risk comparison. The pharmacokinetics of darifenacin at steady state are dose-dependent, due to saturation of the CYP2D6 enzyme. Darifenacin works on the muscles of the bladder to prevent them from causing incontinence.

A single copy of these materials may be reprinted for noncommercial personal use only. Darifenacin is excreted in the milk of rats.

Skin and subcutaneous tissue disorders. Angioedema may be life-threatening and requires immediate medical attention.

U.S. Prescribing Information Disclaimer

Potent P-glycoprotein inhibitors such as ciclosporin and verapamil should also be avoided. After 2 weeks of starting therapy, patients should be reassessed. As with any other antimuscarinic agents, concomitant use of medicinal products that possess antimuscarinic properties, such as oxybutynin, tolterodine and flavoxate, may result in more pronounced therapeutic packagge side effects.

Calcium hydrogen phosphate, anhydrous Hypromellose Magnesium stearate Film coat: